source
- Veradermics reports positive late-stage results for oral hair-loss pill VDPHL01Veradermics announced that its experimental oral medication VDPHL01 met its primary goals in a Phase 3 trial for male pattern hair loss. Over six months, participants taking the drug once or twice…
- Insider explains the true purpose behind prior authorizations in U.S. health insuranceThe STAT+ newsletter article by Bob Herman reports on an interview with Archelle Georgiou, who previously worked at the nation’s largest health insurer and was involved in efforts to curb prior aut…